SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-008051
Filing Date
2020-09-22
Accepted
2020-09-22 17:37:48
Documents
1
Period of Report
2020-09-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-49729.html 4  
1 PRIMARY DOCUMENT marketforms-49729.xml 4 3943
  Complete submission text file 0001214659-20-008051.txt   5445
Mailing Address ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
MORRIS TIMOTHY E (Reporting) CIK: 0001191286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 201190390

Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations